Showing results (41-50 of 57) with videos related to
Sort By:
Pageof 6
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 15, 2011
Pretreatment EGFR T790M mutation and BRCA1 mRNA expression in erlotinib-treated advanced non-small-cell lung cancer patients with EGFR mutationsRafael Rosell, Miguel Angel Molina, Carlota Costa, et al.JAMA Oncology|July 17, 2015
Association of EGFR L858R Mutation in Circulating Free DNA With Survival in the EURTAC TrialNiki Karachaliou, Clara Mayo-de las Casas, Cristina Queralt, et al.Clinical and Translational Medicine|July 29, 2021
Blood biomarkers associated to complete pathological response on NSCLC patients treated with neoadjuvant chemoimmunotherapy included in NADIM clinical trialRaquel Laza-Briviesca, Alberto Cruz-Bermúdez, Ernest Nadal, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2022
Overall Survival and Biomarker Analysis of Neoadjuvant Nivolumab Plus Chemotherapy in Operable Stage IIIA Non-Small-Cell Lung Cancer (NADIM phase II trial)Mariano Provencio, Roberto Serna-Blasco, Ernest Nadal, et al.Molecular Oncology|October 27, 2020
Comprehensive cross-platform comparison of methods for non-invasive EGFR mutation testing: results of the RING observational trialAtocha Romero, Eloisa Jantus-Lewintre, Beatriz García-Peláez, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2026
Decoding B Cell Signatures of Complete Pathological Response to Perioperative Chemoimmunotherapy in Non-Small Cell Lung CancerBelén Sierra-Rodero, Ángeles Gil-González, Marta Molina-Alejandre, et al.British Journal of Cancer|September 8, 2021
Molecular profiling of advanced solid tumours. The impact of experimental molecular-matched therapies on cancer patient outcomes in early-phase trials: the MAST studyValentina Gambardella, Pasquale Lombardi, Juan Antonio Carbonell-Asins, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2021
Pretreatment Tissue TCR Repertoire Evenness Is Associated with Complete Pathologic Response in Patients with NSCLC Receiving Neoadjuvant ChemoimmunotherapyMarta Casarrubios, Alberto Cruz-Bermúdez, Ernest Nadal, et al.The New England Journal of Medicine|June 28, 2023
Perioperative Nivolumab and Chemotherapy in Stage III Non-Small-Cell Lung CancerMariano Provencio, Ernest Nadal, José L González-Larriba, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 13, 2019
Safety and Efficacy of Crizotinib in Patients With Advanced or Metastatic ROS1-Rearranged Lung Cancer (EUCROSS): A European Phase II Clinical TrialSebastian Michels, Bartomeu Massutí, Hans-Ulrich Schildhaus, et al.Pageof 6